{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:57:47Z","timestamp":1788983867320,"version":"build-2803163510"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cerebral vasospasm (CVS) is a major complication of subarachnoid hemorrhage (SAH). Inflammation and nitric oxide (NO) have become increasingly recognized as key pathogenic contributors to brain injury in this condition. We aimed to examine the role of FTY720 in CVS after SAH. Endovascular perforation was used to establish an SAH model. Seventy-five male Sprague\u2013Dawley rats were randomly divided into five groups: sham, sham + FTY720, SAH + saline, and two SAH + FTY720 (0.5 and 1 mg\/kg) groups. The results showed that FTY720 treatment in both the surgery and nonsurgery groups decreased the counts of leukocytes and lymphocytes 72 hours after SAH. TNF-\u03b1 (tumor necrosis factor alpha) and IL-1\u03b2 (interleukin 1 beta) in both the cerebrospinal fluid (CSF) and the hippocampus were decreased, and the NF-\u03baB (nuclear factor kappa B) pathway was inhibited. The levels of apoptotic proteins were downregulated. FTY720 promoted NO generation by activating the PI3K\/AKT\/eNOS pathway. CVS and neurological deficits in the SAH rats were ameliorated after FTY720 treatment. Compared with the sham-only animals, FTY720 treatment in the nonsurgery group did not increase mortality. These results indicated that FTY720 could alleviate CVS due to its anti-inflammatory and antiapoptosis effects and the promotion of NO generation. FTY720 may be effective in the clinical treatment of SAH patients.<\/jats:p>","DOI":"10.4103\/0028-3886.355128","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:36:16Z","timestamp":1664152576000},"page":"1517-1524","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["FTY720 Attenuates Cerebral Vasospasm After Subarachnoid Hemorrhage Through the PI3K\/AKT\/eNOS and NF-\u03baB Pathways in Rats"],"prefix":"10.4103","volume":"70","author":[{"given":"Feng","family":"Kuai","sequence":"first","affiliation":[{"name":"Department of Geriatrics, The First People's Hospital of Yancheng, The Fourth Affiliated Hospital of Nantong University, Yancheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, The First People's Hospital of Yancheng, The Fourth Affiliated Hospital of Nantong University, Yancheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, The First People's Hospital of Yancheng, The Fourth Affiliated Hospital of Nantong University, Yancheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[{"name":"Neurology, The First People's Hospital of Yancheng, The Fourth Affiliated Hospital of Nantong University, Yancheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"R1-20250921","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jocn.2016.09.028","article-title":"Scutellarin attenuates vasospasm through the Erk5-KLF2-eNOS pathway after subarachnoid hemorrhage in rats","volume":"34","author":"Li","year":"2016","journal-title":"J Clin Neurosci"},{"key":"R2-20250921","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","article-title":"Delayed neurological deterioration after subarachnoid haemorrhage","volume":"10","author":"Macdonald","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"R3-20250921","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jocn.2014.08.026","article-title":"Mean hemoglobin concentration after acute subarachnoid hemorrhage and the relation to outcome, mortality, vasospasm, and brain infarction","volume":"22","author":"Stein","year":"2015","journal-title":"J Clin Neurosci"},{"key":"R4-20250921","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/STROKEAHA.108.191395","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association","volume":"40","author":"Bederson","year":"2009","journal-title":"Stroke"},{"key":"R5-20250921","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/0028-3886.79127","article-title":"Continuous intravertebral injection of fasudil hydrochloride in the treatment of cerebral vasospasm","volume":"59","author":"Liu","year":"2011","journal-title":"Neurol India"},{"key":"R6-20250921","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrneurol.2013.11","article-title":"Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage","volume":"9","author":"Budohoski","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R7-20250921","first-page":"e139570","article-title":"Scutellarin's cardiovascular endothelium protective mechanism: Important role of PKG-I\u03b1","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"R8-20250921","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature12722","article-title":"Dysfunctional nitric oxide signalling increases risk of myocardial infarction","volume":"504","author":"Erdmann","year":"2013","journal-title":"Nature"},{"key":"R9-20250921","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1749-6632.2012.06582.x","article-title":"Nitric oxide signaling in the brain: Translation of dynamics into respiration control and neurovascular coupling","volume":"1259","author":"Erdmann","year":"2012","journal-title":"Ann Ny Acad Sci"},{"key":"R10-20250921","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1161\/hs1201.099525","article-title":"Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: Possible role in pathogenesis of cerebral vasospasm","volume":"32","author":"Tosaka","year":"2001","journal-title":"Stroke"},{"key":"R11-20250921","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"R12-20250921","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nm1060","article-title":"Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling","volume":"10","author":"Brinkmann","year":"2004","journal-title":"Nat Med"},{"key":"R13-20250921","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1179\/174313208X300369","article-title":"Influence of acetylsalicylate on plasma lysophosphatidic acid level in patients with ischemic cerebral vascular diseases","volume":"30","author":"Li","year":"2013","journal-title":"Neurol Res"},{"key":"R14-20250921","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10571-011-9650-0","article-title":"Modulation of LPA Receptor Expression in the Human Brain Following Neurotrauma","volume":"31","author":"Frugier","year":"2011","journal-title":"Cell Mol Neurobiol"},{"key":"R15-20250921","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.22186","article-title":"Fingolimod provides long-term protection in rodent models of cerebral ischemia","volume":"69","author":"Wei","year":"2011","journal-title":"Ann Neurol"},{"key":"R16-20250921","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-7091-0693-8_36","article-title":"FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice","volume":"111","author":"Rolland","year":"2011","journal-title":"Acta Neurochir Suppl"},{"key":"R17-20250921","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/STROKEAHA.109.568899","article-title":"Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats","volume":"41","author":"Hasegawa","year":"2010","journal-title":"Stroke"},{"key":"R18-20250921","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jnr.23542","article-title":"Changes in the metabolism of sphingolipids after subarachnoid hemorrhage","volume":"93","author":"Testai","year":"2015","journal-title":"J Neurosci Res"},{"key":"R19-20250921","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12974-015-0234-7","article-title":"Protective role of fingolimod (FTY720) in rats subjected to subarachnoid hemorrhage","volume":"12","author":"Xu","year":"2015","journal-title":"J Neuroinflammation"},{"key":"R20-20250921","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.4103\/neuroindia.NI_357_16","article-title":"A novel swine model of subarachnoid hemorrhage-induced cerebral vasospasm","volume":"65","author":"Zibly","year":"2017","journal-title":"Neurol India"},{"key":"R21-20250921","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-0270(00)00156-4","article-title":"Experimental models of subarachnoid hemorrhage in the rat: A refinement of the endovascular filament model","volume":"96","author":"Schwartz","year":"2000","journal-title":"J Neurosci Meth"},{"key":"R22-20250921","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neulet.2015.01.005","article-title":"Administration of a PTEN inhibitor BPV (pic) attenuates early brain injury via modulating AMPA receptor subunits after subarachnoid hemorrhage in rats","volume":"588","author":"Chen","year":"2015","journal-title":"Neurosci Lett"},{"key":"R23-20250921","first-page":"43","article-title":"Apoptotic mechanisms for neuronal cells in early brain injury after subarachnoid hemorrhage","volume":"110","author":"Hasegawa","year":"2011","journal-title":"Acta Neurochir Suppl"},{"key":"R24-20250921","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1471-4159.2012.07939.x","article-title":"Transition of research focus from vasospasm to early brain injury after subarachnoid hemorrhage","volume":"123","author":"Caner","year":"2012","journal-title":"J Neurochem"},{"key":"R25-20250921","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.70.4.534","article-title":"Inflammatory cytokines in subarachnoid haemorrhage: Association with abnormal blood flow velocities in basal cerebral arteries","volume":"70","author":"Fassbender","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R26-20250921","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/FJC.0b013e3180cbd0e7","article-title":"Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats","volume":"50","author":"Lin","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"R27-20250921","doi-asserted-by":"crossref","first-page":"22070","DOI":"10.1038\/srep22070","article-title":"Hemoglobin induced NO\/cGMP suppression deteriorate microcirculation via pericyte phenotype transformation after subarachnoid hemorrhage in rats","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"R28-20250921","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-4886(03)00082-7","article-title":"Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: A study in green fluorescent protein transgenic bone marrow chimeric mice","volume":"183","author":"Schilling","year":"2003","journal-title":"Exp Neurol"},{"key":"R29-20250921","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/STROKEAHA.108.531632","article-title":"Apoptotic Mechanisms After Cerebral Ischemia","volume":"40","author":"Broughton","year":"2009","journal-title":"Stroke"},{"key":"R30-20250921","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/bj3520809","article-title":"Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions","volume":"352","author":"Murata","year":"2000","journal-title":"Biochem J"},{"key":"R31-20250921","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbalip.2012.07.015","article-title":"Lysophospholipids and their receptors in the central nervous system","volume":"1831","author":"Choi","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"R32-20250921","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.yexmp.2014.07.008","article-title":"FTY720 attenuates hypoxia\u2013reoxygenation-induced apoptosis in cardiomyocytes","volume":"97","author":"Wang","year":"2014","journal-title":"Exp Mol Pathol"},{"issue":"8 Suppl 3","key":"R33-20250921","first-page":"S9","article-title":"The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators","volume":"76","author":"Soliven","year":"2011","journal-title":"Neurology"},{"key":"R34-20250921","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2040-7378-3-2","article-title":"Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice","volume":"3","author":"Pfeilschifter","year":"2011","journal-title":"Transl Stroke Res"},{"key":"R35-20250921","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1177\/1352458515600249","article-title":"Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing-remitting multiple sclerosis three months after childbirth","volume":"21","author":"Kraemer","year":"2015","journal-title":"Mult Scler"},{"key":"R36-20250921","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/mi.2.1.22","article-title":"Inhibition of nuclear factor kappa B (NF-B): An emerging theme in anti-inflammatory therapies","volume":"2","author":"D'Acquisto","year":"2002","journal-title":"Mol Interv"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.355128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:58Z","timestamp":1787067658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.355128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/0028-3886.355128","relation":{},"ISSN":["0028-3886","1998-4022"],"issn-type":[{"value":"0028-3886","type":"print"},{"value":"1998-4022","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"2019-04-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}